Vivek Subbiah, MD, considers artificial intelligence (AI) and comprehensive somatic and germline testing essential for guiding precision oncology and improving patient care.

ELISA (Enzyme-Linked Immunosorbent Assay) has been the mainstay of diagnostic test, not only in India, but also in the rest of the world over the last fifty-odd years. The ELISA plate was associated ...

BENGALURU: Gone are the days when a heart attack or cancer were associated with stress, unhealthy lifestyle and bad eating ...

The findings support a new Human Immune Dysregulation Evaluation Framework (Hi-DEF), according to researchers, which categorizes patients into 4 immune states: myeloid dysregulation, lymphoid ...

Using microscopic worms, researchers can now rapidly create genetic “avatars” of rare diseases – worms engineered to carry ...

New research from the MRC Laboratory of Medical Sciences (LMS) provides a powerful, scalable method for finding treatments ...

The Asia-Pacific is aging rapidly, creating economic and social pressures, while digital health and AI offer solutions to ...

Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — ...

CBSC’s exclusive Canadian distributor, Your Heart Protector Corp. (Calgary, Alberta), has placed an initial order for CardioHolter AT devices totaling $375,000 USD. Delivery of the first 1,000 devices ...

Quest Diagnostics Incorporated ( NYSE: DGX) Jefferies 2025 Healthcare Services Conference September 29, 2025 4:35 PM EDT Okay, we're going to kick it off. I'm Tycho Peterson from the life science team ...

Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to ...

After months of aid cuts, the State Department has released a 35-page document detailing how it plans to roll out global ...